NDC 1308
NDC 1308 is an estradiol analogue. NDC 1308 can bind estrogen receptor beta and inhibit cancer cell proliferation by blocking chromosome replication. NDC 1308 can be used for the research of cancer, such as breast cancer[1].
Product Specifications
CAS Number
1227511-09-2
UNSPSC
12352005
Target
DNA/RNA Synthesis; Estrogen Receptor/ERR
Related Pathways
Cell Cycle/DNA Damage; Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
C[C@@]12[C@](CC[C@@H]2O)([H])[C@@]3([H])[C@](C4=CC=C(O)C=C4[C@H](CCCCCCOC)C3)([H])CC1
Molecular Formula
C25H38O3
Molecular Weight
386.57
References & Citations
[1]Weitman S D, et al. A steroid-based drug that binds estrogen receptor beta can inhibit cancer cell proliferation by blocking chromosome replication[J]. Cancer Research, 2010, 70 (8_Supplement) : 1721-1721.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
464816-01 10 mg
Ropivacaine Hydrochloride Monohydrate discontinued. See 020729
Sign In for Pricing
View Details 464816-02 25 mg
Ropivacaine Hydrochloride Monohydrate discontinued. See 020729
Sign In for Pricing
View Details 
sc-494258 5 mg
3,4-Diethoxy-N-{1-[3- (2-thienyl) -1H-pyrazol-5-yl]piperidin-4-yl}benzamide
Sign In for Pricing
View Details MBS7158752 Inquire
Rabbit anti-Escherichia coli (strain K12) RHSE Polyclonal Antibody
Sign In for Pricing
View Details